Skip to main content
PharmAbcine Inc. logo

PharmAbcine Inc. — Investor Relations & Filings

Ticker · 208340 ISIN · KR7208340000 KO Manufacturing
Open in API
Filings indexed 461 across all filing types
Latest filing 2024-09-27 Director's Dealing
Country KR South Korea
Listing KO 208340

About PharmAbcine Inc.

http://pharmabcine.com/

PharmAbcine Inc. is a clinical-stage biotechnology company specializing in the development of fully human therapeutic monoclonal antibodies (mAbs). The company focuses on creating innovative treatments for diseases with high unmet medical needs, primarily in oncology, neovascular eye diseases, and other inflammatory and vascular disorders. Utilizing its proprietary human antibody library and discovery technologies, PharmAbcine advances a pipeline of next-generation IgG-based therapeutics. The company's mission is to contribute to human health by providing novel antibody-based drugs to patients.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in share ownership by company insiders (directors/executives). According to the provided definitions, reports of personal share transactions by company directors and executives are classified as 'Director's Dealing'.
2024-09-27 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of an Extraordinary General Meeting (EGM) held on 2024-09-27. It details the voting outcomes regarding the appointment of directors (사내이사 선임의 건). According to the provided definitions, the category 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is specifically for official results from shareholder votes at any general meeting.
2024-09-27 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to report changes in share ownership by company insiders (directors/executives). According to the provided definitions, this falls under 'Director's Dealing' (DIRS), which covers personal share transactions and ownership changes by company directors and executives.
2024-09-27 Korean
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) issued by PharmAbcine. It contains the meeting agenda, date, location, and detailed management information regarding board activities, director compensation, and business overview as required by Korean commercial law for shareholder meetings. This document is a formal proxy statement/information circular provided to shareholders to solicit their participation and votes for the upcoming meeting.
2024-09-12 Korean
기타경영사항(자율공시) (소규모 합병 승인 이사회 결의(주주총회 갈음) 결과보고)
AGM Information Classification · 100% confidence The document is an official announcement regarding the approval of a small-scale merger (소규모 합병) between PharmAbcine and Good Tire Co., Ltd. It details the board resolution results, merger ratios, and the absence of shareholder dissent exceeding the legal threshold. Since this document pertains to a merger proposal and its subsequent approval process, it falls under the M&A Activity category.
2024-09-11 Korean
기타시장안내 (코스닥시장위원회 심의·의결 결과 및 개선기간 부여 안내)
Delisting Announcement Classification · 100% confidence The document is a short regulatory announcement from the KOSDAQ market committee regarding the listing status of PharmAbcine. It details the decision to grant an improvement period rather than immediate delisting. Since it is a regulatory notice regarding market status and listing procedures rather than a formal delisting announcement or a financial report, it falls under the general regulatory filings category.
2024-09-06 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.